Skip to main content
Figure 3 | Cancer Cell International

Figure 3

From: Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter

Figure 3

Induction of apoptosis by Ad/gTRAIL: (A) Meningioma cells and (B) glioma cells were treated with PBS, Ad/CMV-GFP or Ad/gTRAIL at MOI of 1000 VPs/ cell. Apoptosis were determined by flow cytometric assay at 4 days after the treatment. On the left side, the name of cell lines; at the top, treatments; and percentages of apoptosis are shown.

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us